Division of Endocrinology, Clinical and Translational Science Institute, The Lundquist Institute at Harbor-UCLA Medical Center, Harbor-UCLA Medical Center, 1124 West Carson Street, Torrance, CA 90502, USA.
Division of Endocrinology, The Lundquist Institute and Harbor-UCLA Medical Center, 1124 West Carson Street, Torrance, CA 90502, USA.
Endocrinol Metab Clin North Am. 2022 Mar;51(1):77-98. doi: 10.1016/j.ecl.2021.11.005. Epub 2022 Feb 8.
All approved testosterone replacement methods, when used according to recommendations, can restore normal serum testosterone concentrations, and relieve symptoms in most hypogonadal men. Selection of the method depends on the patient's preference with advice from the physician. Dose adjustment is possible with most delivery methods but may not be necessary in all hypogonadal men. The use of hepatotoxic androgens must be avoided. Testosterone treatment induces reversible suppression of spermatogenesis; if fertility is desired in the near future, human chronic gonadotropin, selective estrogen receptor modulator, estrogen antagonist, or an aromatase inhibitor that stimulates endogenous testosterone production may be used.
所有经批准的睾酮替代疗法,只要按照建议使用,都可以恢复正常的血清睾酮浓度,并缓解大多数性腺功能减退症男性的症状。方法的选择取决于患者的偏好,并由医生提供建议。大多数给药方法都可以进行剂量调整,但并非所有性腺功能减退症男性都需要调整。必须避免使用肝毒性雄激素。睾酮治疗会导致精子发生可逆抑制;如果近期有生育需求,可以使用人绒毛膜促性腺激素、选择性雌激素受体调节剂、雌激素拮抗剂或刺激内源性睾酮产生的芳香化酶抑制剂。